PEDIATRIX MEDICAL GROUP INC (MD) Forecast, Price Target & Analyst Ratings

NYSE:MD • US58502B1061

Current stock price

19.7 USD
-0.19 (-0.96%)
At close:
19.7 USD
0 (0%)
After Hours:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for PEDIATRIX MEDICAL GROUP INC (MD).

Forecast Snapshot

Consensus Price Target

Price Target
$21.93
+ 11.32% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
May 4, 2026
Period
Q1 / 2026
EPS Estimate
$0.39
Revenue Estimate
479.66M
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
78.67%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$21.93
Upside
+ 11.32%
From current price of $19.70 to mean target of $21.93, Based on 15 analyst forecasts
Low
$19.19
Median
$21.42
High
$25.20

Price Target Revisions

1 Month
-5.15%
3 Months
-5.15%

Price Target Summary

15 Wall Street analysts provided a forecast for the next 12 months for MD. The average price target is 21.93 USD. This implies a price increase of 11.32% is expected in the next year compared to the current price of 19.7.
The average price target has been revised downward by 5.15% in the past 3 months.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

MD Current Analyst RatingMD Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 1 2 3 4 5

Analyst Ratings History

MD Historical Analyst RatingsMD Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 5 10 15

Analyst Ratings Consensus

ChartMill Buy Consensus
78.67%
MD was analyzed by 15 analysts. The buy percentage consensus is at 79. So analysts seem to be have mildly positive about MD.
In the previous month the buy percentage consensus was at a similar level.
MD was analyzed by 15 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2026-02-24UBSMaintains Neutral -> Neutral
2026-02-20Truist SecuritiesMaintains Hold -> Hold
2025-11-10Truist SecuritiesMaintains Hold -> Hold
2025-11-05UBSMaintains Neutral -> Neutral
2025-09-05Leerink PartnersMaintains Market Perform -> Market Perform
2025-08-14UBSMaintains Neutral -> Neutral
2025-05-12UBSMaintains Neutral -> Neutral
2025-05-08MacquarieMaintains Outperform -> Outperform
2025-04-11Truist SecuritiesMaintains Hold -> Hold
2025-02-21UBSMaintains Neutral -> Neutral
2025-02-21Truist SecuritiesMaintains Hold -> Hold
2025-01-06Truist SecuritiesMaintains Hold -> Hold
2024-12-16MacquarieInitiate Outperform
2024-11-19MizuhoMaintains Neutral -> Neutral
2024-11-05UBSMaintains Neutral -> Neutral
2024-11-05JefferiesMaintains Buy -> Buy
2024-11-04MizuhoMaintains Neutral -> Neutral
2024-11-04Deutsche BankMaintains Hold -> Hold
2024-11-04Truist SecuritiesMaintains Hold -> Hold
2024-10-07Truist SecuritiesMaintains Hold -> Hold
2024-09-26JefferiesUpgrade Hold -> Buy
2024-08-15Truist SecuritiesMaintains Hold -> Hold
2024-08-09UBSMaintains Neutral -> Neutral
2024-07-15Truist SecuritiesMaintains Hold -> Hold
2024-06-07Deutsche BankUpgrade Sell -> Hold

Next Earnings Forecast Details

Next Earnings Details

Release Date
May 4, 2026
Period
Q1 / 2026
EPS Estimate
$0.39
Revenue Estimate
479.66M
Revenue Q2Q
4.65%
EPS Q2Q
18.12%
Number of Analysts
10

Next Earnings Revisions

Revenue (1 Month)
-1.72%
Revenue (3 Months)
-1.72%
EPS (1 Month)
-1.30%
EPS (3 Months)
-1.30%

Next Earnings Summary

MD is expected to report earnings on 5/4/2026. The consensus EPS estimate for the next earnings is 0.39 USD and the consensus revenue estimate is 479.66M USD.
The next earnings revenue estimate has been revised downward by 1.72% in the past 3 months.
→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2023 2024 2025 2026 2027 2028 2029
Revenue
YoY % growth
MD revenue by date.MD revenue by date.
1.995B
1.15%		2.013B
0.92%		1.914B
-4.92%		1.985B
3.72%		2.037B
2.62%		2.132B
4.66%		2.291B
7.46%
EBITDA
YoY % growth
MD ebitda by date.MD ebitda by date.
194.023M
-17.66%		215.907M
11.28%		252.912M
17.14%		295.24M
16.74%		301.09M
1.98%		309.55M
2.81%		N/A
EBIT
YoY % growth
MD ebit by date.MD ebit by date.
157.852M
-21.07%		183.681M
16.36%		231.085M
25.81%		255.12M
10.40%		254.85M
-0.11%		238.86M
-6.27%		N/A
Operating Margin
MD operating margin by date.MD operating margin by date.
7.91%9.13%12.07%12.85%12.51%11.20%N/A
EPS
YoY % growth
MD eps by date.MD eps by date.
1.26
-24.55%		1.49
18.25%		2.03
36.24%		2.30
13.36%		2.40
4.18%		2.34
-2.33%		2.11
-9.82%

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26 Q1 / 27 Q2 / 27 Q3 / 27 Q4 / 27
EPS
Q2Q % growth		0.39
18.12%		0.61
14.94%		0.67
-0.56%		0.60
20.78%		0.41
4.51%		0.62
2.38%		0.76
13.94%		0.61
0.28%
Revenue
Q2Q % growth		479.66M
4.65%		489.35M
4.37%		518.31M
5.16%		524.2M
6.16%		500M
4.24%		512.32M
4.69%		532.92M
2.82%		522.5M
-0.32%
EBITDA
Q2Q % growth		53.766M
22.09%		78.379M
5.42%		83.661M
-7.25%		78.34M
2.41%		55.682M
3.56%		80.237M
2.37%		93.771M
12.08%		71.925M
-8.19%
EBIT
Q2Q % growth		44.012M
13.71%		68.405M
7.38%		76.328M
3.14%		68.137M
24.63%		49.821M
13.20%		74.242M
8.53%		87.488M
14.62%		65.838M
-3.37%

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

MD Yearly Revenue VS EstimatesMD Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 1B 2B 3B
MD Yearly EPS VS EstimatesMD Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 1 2 3 4

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
4.87%
EPS Next 5 Year
0.99%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
2.77%
Revenue Next 5 Year
3.93%

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
6.84%
EBIT Next 5 Year
N/A
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

PEDIATRIX MEDICAL GROUP INC / MD Forecast FAQ

What is the average price target for PEDIATRIX MEDICAL GROUP INC (MD) stock?

15 analysts have analysed MD and the average price target is 21.93 USD. This implies a price increase of 11.32% is expected in the next year compared to the current price of 19.7.

What is the next earnings date for MD stock?

PEDIATRIX MEDICAL GROUP INC (MD) will report earnings on 2026-05-04, before the market open.

What are the consensus estimates for PEDIATRIX MEDICAL GROUP INC (MD) next earnings?

The consensus EPS estimate for the next earnings of PEDIATRIX MEDICAL GROUP INC (MD) is 0.39 USD and the consensus revenue estimate is 479.66M USD.

What is the consensus rating for PEDIATRIX MEDICAL GROUP INC (MD) stock?

The consensus rating for PEDIATRIX MEDICAL GROUP INC (MD) is 78.6667 / 100 . This indicates that analysts generally have a positive outlook on the stock.